Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Response of undifferentiated and dedifferentiated endometrial cancer to pembrolizumab: a case report.
Journal: Anti-cancer drugs
Published: December 24, 2025
Frailty and body composition as predictors of postoperative outcomes in patients with epithelial ovarian cancer undergoing neoadjuvant chemotherapy.
Journal: Gynecologic oncology
Published: August 17, 2025
High-grade endometrial cancer presents with malignancy-associated disseminated intravascular coagulation: A case report.
Journal: Gynecologic oncology reports
Published: April 06, 2025
Maintenance bevacizumab following chemotherapy is associated with improved survival in patients with advanced and recurrent cervical cancer in a single-institution retrospective study.
Journal: Gynecologic oncology reports
Published: January 01, 2025
Feasibility and safety of hyperthermic intra-peritoneal chemotherapy in patients with ovarian cancer and chronic kidney disease.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: October 19, 2024
The modified 5-factor frailty index predicts postoperative outcomes in patients with ovarian cancer undergoing hyperthermic intraperitoneal chemotherapy.
Journal: Surgical oncology
Published: June 25, 2024
Fam-Trastuzumab Deruxtecan in HER2/Neu-Expressing Serous Endometrial Cancer.
Journal: JCO precision oncology
Published: August 18, 2023
Preoperative assessment using the five-factor modified frailty index: A call for standardized preoperative assessment and prehabilitation services in gynecologic oncology.
Journal: Gynecologic oncology
Published: February 27, 2022
Showing 1-8 of 8
Last Updated: 09/26/2026